Literature DB >> 21917992

Extracellular matrix degradation and remodeling in development and disease.

Pengfei Lu1, Ken Takai, Valerie M Weaver, Zena Werb.   

Abstract

The extracellular matrix (ECM) serves diverse functions and is a major component of the cellular microenvironment. The ECM is a highly dynamic structure, constantly undergoing a remodeling process where ECM components are deposited, degraded, or otherwise modified. ECM dynamics are indispensible during restructuring of tissue architecture. ECM remodeling is an important mechanism whereby cell differentiation can be regulated, including processes such as the establishment and maintenance of stem cell niches, branching morphogenesis, angiogenesis, bone remodeling, and wound repair. In contrast, abnormal ECM dynamics lead to deregulated cell proliferation and invasion, failure of cell death, and loss of cell differentiation, resulting in congenital defects and pathological processes including tissue fibrosis and cancer. Understanding the mechanisms of ECM remodeling and its regulation, therefore, is essential for developing new therapeutic interventions for diseases and novel strategies for tissue engineering and regenerative medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917992      PMCID: PMC3225943          DOI: 10.1101/cshperspect.a005058

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  125 in total

Review 1.  ECM degrading proteases and tissue remodelling in the mammary gland.

Authors:  Kirsty A Green; Leif R Lund
Journal:  Bioessays       Date:  2005-09       Impact factor: 4.345

Review 2.  The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.

Authors:  Keith Brew; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2010-01-15

Review 3.  Intrinsic extracellular matrix properties regulate stem cell differentiation.

Authors:  Gwendolen C Reilly; Adam J Engler
Journal:  J Biomech       Date:  2009-10-02       Impact factor: 2.712

Review 4.  Proteinases involved in matrix turnover during cartilage and bone breakdown.

Authors:  Tim E Cawston; David A Young
Journal:  Cell Tissue Res       Date:  2009-11-14       Impact factor: 5.249

Review 5.  The extracellular matrix in development and morphogenesis: a dynamic view.

Authors:  Tania Rozario; Douglas W DeSimone
Journal:  Dev Biol       Date:  2009-10-23       Impact factor: 3.582

Review 6.  Regulation of cell signalling by uPAR.

Authors:  Harvey W Smith; Chris J Marshall
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

Review 7.  Matrix metalloproteinases: regulators of the tumor microenvironment.

Authors:  Kai Kessenbrock; Vicki Plaks; Zena Werb
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

8.  Spatial restriction of FGF signaling by a matrix metalloprotease controls branching morphogenesis.

Authors:  Qiong Wang; Mirka Uhlirova; Dirk Bohmann
Journal:  Dev Cell       Date:  2010-01-19       Impact factor: 12.270

Review 9.  Morphogenesis of epithelial tubes: Insights into tube formation, elongation, and elaboration.

Authors:  Deborah J Andrew; Andrew J Ewald
Journal:  Dev Biol       Date:  2009-09-22       Impact factor: 3.582

Review 10.  Unraveling metalloproteinase function in skeletal biology and disease using genetically altered mice.

Authors:  Alison Aiken; Rama Khokha
Journal:  Biochim Biophys Acta       Date:  2009-07-17
View more
  651 in total

Review 1.  Head and neck lymphatic tumors and bony abnormalities: a clinical and molecular review.

Authors:  Karthik Balakrishnan; Mark Majesky; Jonathan A Perkins
Journal:  Lymphat Res Biol       Date:  2011       Impact factor: 2.589

Review 2.  Overview of the matrisome--an inventory of extracellular matrix constituents and functions.

Authors:  Richard O Hynes; Alexandra Naba
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

Review 3.  Role of the extracellular matrix in epithelial morphogenesis: a view from C. elegans.

Authors:  Michel Labouesse
Journal:  Organogenesis       Date:  2012-04-01       Impact factor: 2.500

4.  The potential role of leptin in the vascular remodeling associated with obesity.

Authors:  E Martínez-Martínez; M Miana; R Jurado-López; M V Bartolomé; F V Souza Neto; M Salaices; N López-Andrés; V Cachofeiro
Journal:  Int J Obes (Lond)       Date:  2014-03-03       Impact factor: 5.095

5.  LW106, a novel indoleamine 2,3-dioxygenase 1 inhibitor, suppresses tumour progression by limiting stroma-immune crosstalk and cancer stem cell enrichment in tumour micro-environment.

Authors:  Rong Fu; Yi-Wei Zhang; Hong-Mei Li; Wen-Cong Lv; Li Zhao; Qing-Long Guo; Tao Lu; Stephen J Weiss; Zhi-Yu Li; Zhao-Qiu Wu
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

Review 6.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

Review 7.  Matrix remodeling in chronic lung diseases.

Authors:  Bon-Hee Gu; Matthew C Madison; David Corry; Farrah Kheradmand
Journal:  Matrix Biol       Date:  2018-03-17       Impact factor: 11.583

Review 8.  Extracellular matrix and liver disease.

Authors:  Elena Arriazu; Marina Ruiz de Galarreta; Francisco Javier Cubero; Marta Varela-Rey; María Pilar Pérez de Obanos; Tung Ming Leung; Aritz Lopategi; Aitor Benedicto; Ioana Abraham-Enachescu; Natalia Nieto
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

Review 9.  Integrins in Wound Healing.

Authors:  Leeni Koivisto; Jyrki Heino; Lari Häkkinen; Hannu Larjava
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-12-01       Impact factor: 4.730

10.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice.

Authors:  Cheri L Lamb; Giovan N Cholico; Xinzhu Pu; Gerald D Hagler; Kenneth A Cornell; Kristen A Mitchell
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-28       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.